The relative importance of maternal body mass index and glucose levels for prediction of large-for-gestational-age births

BMC Pregnancy and Childbirth

Karin Källén⁴  Claes Ignell²  Rickard Claesson³  Eva Anderberg⁴  Kerstin Berntorp¹ 

[1] Department of Endocrinology, Skåne University Hospital, Malmö, Sweden;Department of Obstetrics and Gynecology, Office for Healthcare “Sund”, Helsingborg, Sweden;Department of Obstetrics and Gynecology, Office for Healthcare “Kryh”, Ystad SE-27182, Sweden;Department of Clinical Sciences Lund, Lund University, Lund, Sweden

关键词: Predicting risk;    Oral glucose tolerance test;    Large-for-gestational-age;    Glucose levels;    Gestational diabetes mellitus;    Body mass index;   

Others  :  1232776
DOI  :  10.1186/s12884-015-0722-x

 received in 2015-06-16, accepted in 2015-10-21,  发布年份 2015

【 摘 要 】

Background

The risk of gestational diabetes mellitus (GDM) increases substantially with increasing maternal body mass index (BMI). The aim of the present study was to evaluate the relative importance of maternal BMI and glucose levels in prediction of large-for-gestational-age (LGA) births.

Method

This observational cohort study was based on women giving birth in southern Sweden during the years 2003–2005. Information on 10 974 pregnancies was retrieved from a population-based perinatal register. A 75-g oral glucose tolerance test (OGTT) was performed in the 28 week of pregnancy for determination of the 2-h plasma glucose concentration. BMI was obtained during the first trimester. The dataset was divided into a development set and a validation set. Using the development set, multiple logistic regression analysis was used to identify maternal characteristics associated with LGA. The prediction of LGA was assessed by receiver-operating characteristic (ROC) curves, with LGA defined as birth weight > +2 standard deviations of the mean.

Results

In the final multivariable model including BMI, 2-h glucose level and maternal demographics, the factor most strongly associated with LGA was BMI (odds ratio 1.1, 95 % confidence interval [CI] 1.08–1.30). Based on the total dataset, the area under the ROC curve (AUC) of 2-h glucose level to predict LGA was 0.54 (95 % CI 0.48–0.60), indicating poor performance. Using the validation database, the AUC for the final multiple model was 0.69 (95 % CI 0.66–0.72), which was identical to the AUC retrieved from a model not including 2-h glucose (0.69, 95 % CI 0.66–0.72), and larger than from a model including 2-h glucose but not BMI (0.63, 95 % CI 0.60–0.67).

Conclusions

Both the 2-h glucose level of the OGTT and maternal BMI had a significant effect on the risk of LGA births, but the relative contribution was higher for BMI. The findings highlight the importance of concentrating on healthy body weight in pregnant women and closer monitoring of weight during pregnancy as a strategy for reducing the risk of excessive fetal growth.

【 授权许可】

   
2015 Berntorp et al.

【 图 表 】

Fig. 1.

Fig. 2.

【 参考文献 】

• [1]Huda SS, Brodie LE, Sattar N. Obesity in pregnancy: prevalence and metabolic consequences. Semin Fetal Neonatal Med. 2010; 15(2):70-6.
• [2]Chu SY, Callaghan WM, Kim SY, Schmid CH, Lau J, England LJ et al.. Maternal obesity and risk of gestational diabetes mellitus. Diabetes Care. 2007; 30(8):2070-6.
• [3]HAPO Study Cooperative Research Group. Hyperglycaemia and Adverse Pregnancy Outcome (HAPO) Study: associations with maternal body mass index. BJOG. 2010;117(5):575–84.
• [4]Catalano PM, McIntyre HD, Cruickshank JK, McCance DR, Dyer AR, Metzger BE et al.. The hyperglycemia and adverse pregnancy outcome study: associations of GDM and obesity with pregnancy outcomes. Diabetes Care. 2012; 35(4):780-6.
• [5]Kim SY, Sharma AJ, Sappenfield W, Wilson HG, Salihu HM. Association of maternal body mass index, excessive weight gain, and gestational diabetes mellitus with large-for-gestational-age births. Obstet Gynecol. 2014; 123(4):737-44.
• [6]Weissmann-Brenner A, Simchen MJ, Zilberberg E, Kalter A, Weisz B, Achiron R et al.. Maternal and neonatal outcomes of large for gestational age pregnancies. Acta Obstet Gynecol Scand. 2012; 91(7):844-9.
• [7]Henriksen T. The macrosomic fetus: a challenge in current obstetrics. Acta Obstet Gynecol Scand. 2008;87(2) :134–45.
• [8]Surkan PJ, Hsieh CC, Johansson AL, Dickman PW, Cnattingius S. Reasons for increasing trends in large for gestational age births. Obstet Gynecol. 2004; 104(4):720-6.
• [9]Ekblad M, Gissler M, Korkeila J, Lehtonen L. Trends and risk groups for smoking during pregnancy in Finland and other Nordic countries. Eur J Public Health. 2014;24(4) :544–51.
• [10]Anderberg E, Källen K, Berntorp K, Frid A, Aberg A. A simplified oral glucose tolerance test in pregnancy: compliance and results. Acta Obstet Gynecol Scand. 2007; 86(12):1432-6.
• [11]Anderberg E, Källen K, Berntorp K. The impact of gestational diabetes mellitus on pregnancy outcome comparing different cut-off criteria for abnormal glucose tolerance. Acta Obstet Gynecol Scand. 2010; 89(12):1532-7.
• [12]Lind T, Phillips PR. Influence of pregnancy on the 75-g OGTT. A prospective multicenter study. The diabetic pregnancy study group of the European association for the study of diabetes. Diabetes. 1991; 40 Suppl 2:8-13.
• [13]Burnett RW, D’Orazio P, Fogh-Andersen N, Kuwa K, Kulpmann WR, Larsson L et al.. IFCC recommendation on reporting results for blood glucose. Clin Chim Acta. 2001; 307(1–2):205-9.
• [14]Molin J. A regional perinatal database in southern Sweden--a basis for quality assurance in obstetrics and neonatology. Acta Obstet Gynecol Scand Suppl. 1997; 164:37-9.
• [15]Maršál K, Persson P-H, Larsen T, Lilja H, Selbing A, Sultan B. Intrauterine growth curves based on ultrasonically estimated foetal weihts. Acta Pediatr. 1996;85(7) :843–8.
• [16]DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988; 44(3):837-45.
• [17]Jiwani A, Marseille E, Lohse N, Damm P, Hod M, Kahn JG. Gestational diabetes mellitus: results from a survey of country prevalence and practices. J Matern Fetal Neonatal Med. 2012; 25(6):600-10.
• [18]Definition, diagnosis and classification of diabetes mellitus and its complications. Part I: diagnosis and classification of diabetes mellitus. World Health Organization, Geneva; 1999.
• [19]Jensen DM, Damm P, Sorensen B, Molsted-Pedersen L, Westergaard JG, Ovesen P et al.. Pregnancy outcome and prepregnancy body mass index in 2459 glucose-tolerant Danish women. Am J Obstet Gynecol. 2003; 189(1):239-44.
• [20]HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991–2002.
• [21]International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33(3):676–82.
• [22]Houshmand A, Jensen DM, Mathiesen ER, Damm P. Evolution of diagnostic criteria for gestational diabetes mellitus. Acta Obstet Gynecol Scand. 2013; 92(7):739-45.
• [23]Sacks DA, Hadden DR, Maresh M, Deerochanawong C, Dyer AR, Metzger BE et al.. Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Diabetes Care. 2012; 35(3):526-8.
• [24]Lindqvist M, Persson M, Lindkvist M, Mogren I. No consensus on gestational diabetes mellitus screening regimes in Sweden: pregnancy outcomes in relation to different screening regimes 2011 to 2012, a cross-sectional study. BMC Pregnancy Childbirth. 2014; 14:185. BioMed Central Full Text
• [25]Ignell C, Berntorp K. Evaluation of the relationship between capillary and venous plasma glucose concentrations obtained by the HemoCue Glucose 201+ system during an oral glucose tolerance test. Scand J Clin Lab Invest. 2011; 71(8):670-5.
• [26]Lindell G, Maršál K, Källen K. Impact of maternal characteristics on fetal growth in the third trimester: a population-based study. Ultrasound Obstet Gynecol. 2012; 40(6):680-7.
• [27]Marshall NE, Guild C, Cheng YW, Caughey AB, Halloran DR. Racial disparities in pregnancy outcomes in obese women. J Matern Fetal Neonatal Med. 2014; 27(2):122-6.
• [28]Oteng-Ntim E, Kopeika J, Seed P, Wandiembe S, Doyle P. Impact of obesity on pregnancy outcome in different ethnic groups: calculating population attributable fractions. PLoS One. 2013; 8(1):e53749.
• [29]Nguyen BT, Cheng YW, Snowden JM, Esakoff TF, Frias AE, Caughey AB. The effect of race/ethnicity on adverse perinatal outcomes among patients with gestational diabetes mellitus. Am J Obstet Gynecol. 2012; 207(4):322.
• [30]Gaillard R, Felix JF, Duijts L, Jaddoe VW. Childhood consequences of maternal obesity and excessive weight gain during pregnancy. Acta Obstet Gynecol Scand. 2014; 93(11):1085-9.
• [31]Jensen DM, Ovesen P, Beck-Nielsen H, Molsted-Pedersen L, Sorensen B, Vinter C et al.. Gestational weight gain and pregnancy outcomes in 481 obese glucose-tolerant women. Diabetes Care. 2005; 28(9):2118-22.
• [32]Ronnberg AK, Nilsson K. Interventions during pregnancy to reduce excessive gestational weight gain: a systematic review assessing current clinical evidence using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) system. BJOG. 2010;117(11) :1327–34.
• [33]Poston L, Harthoorn LF, Van Der Beek EM. Contributors to the ILSI Europe workshop. Obesity in pregnancy: implications for the mother and lifelong health of the child. A consensus statement. Pediatr Res. 2011;69(2):175–80.